Remove 2013 Remove Allergic Reaction Remove ALS
article thumbnail

REBEL Core Cast 108.0 – Angioedema

REBEL EM

Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergic reaction. Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergic reaction. Read More EMCrit: Podcast 145 – Awake Intubation Lecture from SMACC ERCast: Angioedema References: Baş M et al.

article thumbnail

STREAM-2: Half-Dose Tenecteplase vs Primary PCI in Older Patients with STEMI?

REBEL EM

Paper: Van de Werf, F et al. References: Van de Werf, F et al. PMID: 37439219 Armstrong P et al. Based on this, the authors did a literature review and found that there is an increasing rate of ICH and major non-intracranial bleeding starting at ≈60 years of age. Primary PCI: 95.7% Stents Placed: Pharmaco-Invasive Treatment: 97.4%

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CT Angiography Head and Neck: Indications and Limitations

EMDocs

2 Outcomes of patients presenting with ischemic stroke who received MRI as initial imaging modality have demonstrated similar outcomes to those with initial CTA, with Kim et al. In a study of 17,903 CTAs ordered in the ED, Tu et al. 8 The data in Mayer et al. 9 A later assessment of the VAN score in Beume et al.

article thumbnail

Episode 161 Allergies Part 1: Pollens, nuts, & bugs

This Podcast Will Kill You

Sometimes it seems like the world is out to get us: bees in our garden, pollen in the air, nuts in our brownies, any number of other things that could trigger an allergic reaction ranging from itchy eyes and a runny nose all the way to anaphylaxis. Hurley, Sadhbh, et al. Lv, Jia-jie, et al. Marichal, Thomas, et al.

article thumbnail

Episode 162 Allergies Part 2: Shots, pills, & pens

This Podcast Will Kill You

Cataldi, Mauro, et al. Gutermuth, Jan, et al. “111 years of allergen-immunotherapy: a long and successful history of the only available disease-modifier in allergic diseases.” FDA approves first medication to help reduce allergic reactions to multiple foods after accidental exposure. 2013): 966-973.